VTAK — Catheter Precision, Inc.
$0.4876-13.47%
Last close: · regular session
Last 60 sessions
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for VTAK in the TickerWise workspace.
Catheter Precision, Inc., headquartered in Fort Mill, South Carolina, is dedicated to creating and distributing electrophysiology products. Their mission is to enhance treatment and outcomes for U.S. patients suffering from cardiac arrhythmias by providing innovative technologies and solutions to patients, hospitals, and physicians. Their premier product, the View into Ventricular Onset System (VIVO), is a non-invasive 3D cardiac mapping solution designed to accurately locate the origin points of idiopathic ventricular arrhythmias in patients with otherwise healthy hearts, before they undergo electrophysiology procedures. Additionally, they offer LockeT, a device for suture retention, and the Amigo Remote Catheter System, a robotic arm used for precise catheter control. The company, previously known as Ra Medical Systems, Inc., officially adopted the name Catheter Precision, Inc. in August 2023.
Company profile
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
- Exchange: New York Stock Exchange American
- Employees: 22
- Website: https://www.catheterprecision.com
Latest SEC filings for VTAK
Latest VTAK news
- Catheter Precision to rebrand as Flyte Aviation, adopt VJET ticker Read article
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.